Date of first VCS test:  Tue Jan 7 12:44:06 2014 (EST)
Date of most recent VCS test:  Fri Sep 22 18:03:39 2017 (EDT)
Time site in operation:  1354.2 days

Tests with POSITIVE results (suggesting neurotoxin exposure is likely):  72.9%
Tests with NEGATIVE results (suggesting neurotoxin exposure is unlikely):  27.1%


Percentage of VCS test takers responding to at least 1 survey question:  78.5%

Percentage of VCS test takers self-rating their overall health on a scale of 1-10 (10 being highest/best):  77.7%
   Average self-rated overall health among all respondents:  5.76
   Average self-rated overall health among respondents with POSITIVE test results:  5.67
   Average self-rated overall health among respondents with NEGATIVE test results:  6.02

Percentage of VCS test takers who responded regarding recent mold exposure or suspected mold exposure:  77%
   Percentage reporting recent mold exposure or suspected mold exposure:  58.8%
      With POSITIVE test results:  74.4%
      With NEGATIVE test results:  25.6%
   Percentage reporting NO recent mold exposure or suspected mold exposure:  41.2%
      With POSITIVE test results:  70.6%
      With NEGATIVE test results:  29.4%

Percentage of VCS test takers who responded regarding mold illness diagnosis:  45.3%
   Percentage reporting mold illness diagnosis:  20.2%
      With POSITIVE test results:  73.3%
      With NEGATIVE test results:  26.7%
   Percentage reporting NO mold illness diagnosis:  79.8%
      With POSITIVE test results:  74.6%
      With NEGATIVE test results:  25.4%

Percentage of VCS test takers who responded regarding exposures to other neurotoxins:  76.4%
   Percentage reporting exposure to other neurotoxins:  37.9%
      With POSITIVE test results:  73.7%
      With NEGATIVE test results:  26.3%
   Percentage reporting NO exposure to other neurotoxins:  62.1%
      With POSITIVE test results:  72.2%
      With NEGATIVE test results:  27.8%

Percentage of VCS test takers who responded regarding diagnosis with exposure to other neurotoxins:  29.2%
   Percentage reporting diagnosis with exposure to other neurotoxins:  31%
      With POSITIVE test results:  72.2%
      With NEGATIVE test results:  27.8%
   Percentage reporting NO diagnosis with exposure to other neurotoxins:  69%
      With POSITIVE test results:  74%
      With NEGATIVE test results:  26%

Percentage of VCS test takers who responded regarding other conditions involving neurological function:  76.5%
   Percentage reporting suffering from a condition involving neurological function:  28.8%
      With POSITIVE test results:  73.2%
      With NEGATIVE test results:  26.8%
   Percentage reporting suffering from NO condition involving neurological function:  71.2%
      With POSITIVE test results:  72.6%
      With NEGATIVE test results:  27.4%